News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides an overview of Cardio Diagnostics Holdings Inc. (CDIO) executive compensation, noting that specific figures for the highest-paid executive were unavailable at the time of publication. It also details various financial and analytical data points for CDIO, including institutional holdings, insider trading, …
Cardio Diagnostics Holdings, Inc. announced it will host an investor conference call on Thursday, August 20, 2026, at 3 p.m. Central Time. The call will cover the company's precision molecular approach to cardiovascular disease prevention and early detection, including updates on its commercially available …
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is seeking stockholder approval for a significant new stock issuance proposal at its virtual annual meeting on September 18, 2026. The company plans to vote on issuing up to 5.0 million shares or equivalents, valued at up to …
This article provides financial information for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIOW), specifically its enterprise value to revenue forward. It appears to be a financial data page from TradingView, offering an overview of the company's financials.
This article provides a technical analysis of Cardio Diagnostics Holdings Inc (CDIO), covering its support and resistance levels, various technical indicators, and moving averages. The stock's current price momentum score is 5.13, trading between a resistance level of 1.98 and a support level of …
Cardio Diagnostics Holdings Inc (CDIO) currently holds a valuation score of 8.46, placing it 129th out of 384 companies in the Biotechnology & Medical Research industry. The company's P/E ratio stands at 0.06, which is significantly lower than its recent high but substantially above …
Cardio Diagnostics Holdings Inc. (CDIOW) revenue breakdown shows that the greatest contribution came from the United States, accounting for $14.82K USD last year, a decrease from $34.89K USD the year prior. This financial data highlights the company's regional performance and key revenue sources.
Cardio Diagnostics Holdings Inc (CDIO) has a TradingKey stock score indicating relatively healthy fundamentals and high growth potential, though its valuation is considered fairly valued within the Biotechnology & Medical Research industry. The company, an AI-powered precision cardiovascular medicine company, faces risks such as …
This article provides a detailed balance sheet for Cardio Diagnostics Holdings Inc (CDIO) as of its latest reported quarter. It presents both quarterly and annual financial data, including assets, liabilities, and shareholders' equity, allowing for evaluation of the company's financial health, fundamentals, and key …
This article details the shareholder structure of Cardio Diagnostics Holdings Inc (CDIO), listing both major individual and institutional holders. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity with changes in holdings for key investors. The data …
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIOW) revenue breakdown shows that the greatest contribution came from the United States, accounting for $14,820 last year, a decrease from $34,890 the year before. The article specifically details the financial performance by country and source.
Cardio Diagnostics Holdings Inc. (CDIO) shows a "Speculative Buy" analyst consensus with a high price target of $2, representing a 33.3% upside. The short interest is low at 0.7%, indicating minimal bearish sentiment from short-sellers. Recent insider activity includes significant stock option acquisitions by …
Cardio Diagnostics Holdings Inc (CDIO) has an institutional shareholding score of 3.00, placing it 192nd out of 386 in the Biotechnology & Medical Research industry. The institutional shareholding proportion recently decreased by 24.74% quarter-over-quarter, now standing at 4.68%. James Simons is the largest institutional …
Search by ticker symbol or company name and select a result to open its chart.